INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025

Rhea-AI Summary

INOVIO (NASDAQ:INO), a biotechnology company specializing in DNA medicines for HPV-associated diseases, cancers, and infectious diseases, will release its Q2 2025 financial results on August 12, 2025 after market close.

The company will host a conference call and webcast at 4:30 p.m. ET the same day, featuring a general business update and analyst Q&A session. Investors can access the live webcast through INOVIO's investor relations website, with a replay available for 90 days post-event.

News Market Reaction – INO

+0.68%

+0.68% Session close to close

In the Aug 5 session, INO gained 0.68%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PLYMOUTH MEETING, Pa., Aug. 4, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancers, and infectious diseases, today announced that its second quarter 2025 financial results will be released after the market close on August 12, 2025. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss the financial results and provide a general business update.

The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancers, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

Contacts
Media: Jennie Willson, (267) 429-8567, communications@inovio.com
Investors: Peter Vozzo - ICR Healthcare, (443) 213-0505, investor.relations@inovio.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-report-second-quarter-2025-financial-results-on-august-12-2025-302520939.html

SOURCE INOVIO Pharmaceuticals, Inc.

FAQ

When will INOVIO (NASDAQ:INO) release its Q2 2025 earnings?

INOVIO will release its Q2 2025 financial results on August 12, 2025 after the market close.

What time is INOVIO's Q2 2025 earnings call?

INOVIO's earnings conference call and webcast will take place at 4:30 p.m. ET on August 12, 2025.

How can investors access INOVIO's Q2 2025 earnings webcast?

Investors can access the live webcast through INOVIO's investor relations website at http://ir.inovio.com/events-and-presentations/default.aspx.

How long will INOVIO's Q2 2025 earnings webcast be available for replay?

The webcast will be archived and available for replay for 90 days following the event.